U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
6720167201Effect of Long Biliopancreatic Limb RYGB on Weight Loss and ComorbiditiesActive, not recruitingNo Results AvailableMorbid ObesityProcedure: Roux-en-Y Gastric Bypasshttps://ClinicalTrials.gov/show/NCT01686997
6720267202Influence of Inspiratory Flow Pattern on Exchange of Carbon Dioxide in Humans Without Primary Lung DiseaseCompletedNo Results AvailablePulmonary Gas Exchange|Carbon DioxideOther: Altered breathhttps://ClinicalTrials.gov/show/NCT01686984
6720367203The Needs of Cancer SurvivorsNot yet recruitingNo Results AvailableNeeds and Demands of Oncology Patients|Breast Cancer Patients.|Colon Cancer Patients.https://ClinicalTrials.gov/show/NCT01686971
6720467204Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate CancerActive, not recruitingNo Results AvailableProstate CancerDevice: MR-Guided Transurethral US Ablation of Prostate Tissuehttps://ClinicalTrials.gov/show/NCT01686958
6720567205Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2|HealthyDrug: semaglutide|Drug: semaglutide|Drug: semaglutide|Drug: semaglutide|Drug: placebo|Drug: placebohttps://ClinicalTrials.gov/show/NCT01686945
6720667206Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart FunctionActive, not recruitingNo Results AvailableDiabetes Mellitus Type 2Drug: Vildagliptin followed by Sitagliptin|Drug: Sitagliptin followed by Vildagliptinhttps://ClinicalTrials.gov/show/NCT01686932
6720767207Effect of Milk-free Diet on Weight and Irritable Bowel Syndrome in Morbid ObesityWithdrawnNo Results AvailableObesity, MorbidDietary Supplement: milk-freehttps://ClinicalTrials.gov/show/NCT01686919
6720867208Isolated Bowman Layer Graft for Reducing and Stabilizing Advanced KeratoconusRecruitingNo Results AvailableAdvanced KeratoconusProcedure: Bowman layer graft implantationhttps://ClinicalTrials.gov/show/NCT01686906
6720967209Evaluation of Safety and Efficacy of Shorttime TNI Treatment in Patients With COPDRecruitingNo Results AvailableOxygen Inhalation TherapyDevice: Nasal oxygen insufflation with a TNI 20 oxy device|Device: Standard Nasal Insufflation of oxygenhttps://ClinicalTrials.gov/show/NCT01686893
6721067210Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic LiverTerminatedNo Results AvailableHepatocellular Carcinoma|Liver CirrhosisDevice: Sirsphere trans-arterial radioembolizationhttps://ClinicalTrials.gov/show/NCT01686880
6721167211Feasibility Intervention Trial of Two Types of Improved Cookstoves in Three Developing CountriesCompletedNo Results AvailablePoisoning by Carbon Monoxide From Domestic Fuels|Respiratory Conditions Due to Other External AgentsDevice: Improved, ventilated cookstovehttps://ClinicalTrials.gov/show/NCT01686867
6721267212Effectiveness of Cognitive Behavioral Therapy vs. Prescriptive Diet in Short and Medium-term Control of Body WeightActive, not recruitingNo Results AvailableObesityBehavioral: Cognitive Behavioral (B)|Other: Prescriptive Diet (A)https://ClinicalTrials.gov/show/NCT01686854
6721367213A Pilot Clinical Trial Investigating the Effect of Cutaneous Cooling on Sebum ProductionRecruitingNo Results AvailableBody Fat DisorderDevice: The Zeltiq Systemhttps://ClinicalTrials.gov/show/NCT01686841
6721467214T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone InsulinActive, not recruitingNo Results AvailableInsulin Resistance|Type 2 Diabetes Mellitus|Obesity|Androgen Deficiency|Metabolic DiseaseDrug: Acyline|Drug: Testosterone 1.62% gel|Drug: Letrozole|Drug: Placebo gel (for Testosterone 1.62% gel)|Drug: Placebo pill (for Letrozole)https://ClinicalTrials.gov/show/NCT01686828
6721567215Cross-Sectional Iloperidone IVGTTRecruitingNo Results AvailableSchizophrenia|Serious Mental Illness|Metabolic Syndrome|Insulin Resistance|Glucose Metabolismhttps://ClinicalTrials.gov/show/NCT01686815
6721667216Post-operative Oral Morphine Versus IbuprofenRecruitingNo Results AvailablePost-operative PainDrug: oral morphine|Drug: Ibuprofenhttps://ClinicalTrials.gov/show/NCT01686802
6721767217Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4RecruitingNo Results AvailableChronic Hepatitis C VirusDrug: Pegylated interferon alpha-2ahttps://ClinicalTrials.gov/show/NCT01686789
6721867218A Prospective Validation Study of Albumin Kinetics With Tracer 123 I-HSARecruitingNo Results AvailableHealthy|SIRSOther: 123 I-HSA + 125 I HSAhttps://ClinicalTrials.gov/show/NCT01686776
6721967219Endothelin-1 and Methabolites Concentrations in Mycrodialysis and Cerebrospinal Fluid in Subarachnoid Hemorrhage PatientsCompletedNo Results AvailableSubarachnoid Hemorrhage, Aneurysmalhttps://ClinicalTrials.gov/show/NCT01686763
6722067220Integrated Care Centers to Improve HIV Outcomes in Vulnerable Indian PopulationsRecruitingNo Results AvailableHIV InfectionBehavioral: Integrated care centershttps://ClinicalTrials.gov/show/NCT01686750
6722167221Iyengar Yoga for Chemotherapy-induced Fatigue in Breast Cancer PatientsWithdrawnNo Results AvailableBreast Neoplasms|FatigueBehavioral: Iyengar Yoga|Behavioral: Walkinghttps://ClinicalTrials.gov/show/NCT01686737
6722267222Study of the Collaborative Life Skills ProgramRecruitingNo Results AvailableAttention Deficit Hyperactivity Disorder SymptomsBehavioral: Collaborative Life Skills Intervention (CLS)|Other: Business As Usualhttps://ClinicalTrials.gov/show/NCT01686724
6722367223A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322CompletedNo Results AvailableDiabetes MellitusDrug: AD-4833 15 mg|Drug: AD-4833 30 mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01686711
6722467224Effect of VSL#3 on Cognitive Function, Risk of Falls and Quality of Life in Patients With CirrhosisRecruitingNo Results AvailableCirrhosis|Cognitive DysfunctionDietary Supplement: VSL#3|Other: Placebohttps://ClinicalTrials.gov/show/NCT01686698
6722567225Correlation of CXCR4 Expression in Premature Infants With a Diagnosis of Autism at 24 MonthsRecruitingNo Results AvailableAutism Spectrum Disorder|Complication of Prematurityhttps://ClinicalTrials.gov/show/NCT01686685
6722667226Web-based Delivery of Effective Treatment for Growth in Cystic FibrosisCompletedNo Results AvailableCystic FibrosisBehavioral: Web Interventionhttps://ClinicalTrials.gov/show/NCT01686672
6722767227Noninvasive and Continuous Hemoglobin Monitoring for Surgical Blood ManagementRecruitingNo Results AvailableSurgeryDevice: Continuous Noninvasive Hemoglobin Monitoringhttps://ClinicalTrials.gov/show/NCT01686659
6722867228Effects of Two Doses of a Common Cold Treatment on AlertnessCompletedHas ResultsCommon ColdDrug: paracetamol + caffeine|Drug: paracetamolhttps://ClinicalTrials.gov/show/NCT01686646
6722967229An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.CompletedHas ResultsAsthmaDrug: Fluticasone Furoate/ Vilanterol 200/25 mcg|Drug: Fluticasone Furoate/ Vilanterol 100/25 mcg|Drug: Fluticasone Furoate 100 mcghttps://ClinicalTrials.gov/show/NCT01686633
6723067230A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)CompletedNo Results AvailableType 1 Diabetes MellitusDrug: BIOD-123|Drug: Lispro (Humalog)https://ClinicalTrials.gov/show/NCT01686620

* Görseller ve İçerik tekif hakkına sahip olabilir